Robert Kelley's Insider Trades & SAST Disclosures

Robert Kelley's most recent trade in Talis Biomedical Corp was a trade of 500,000 Stock option (right to buy) done . Disclosure was reported to the exchange on April 7, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Talis Biomedical Corp
Robert Kelley Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Apr 2023 500,000 500,000 - - Stock option (right to buy)
Talis Biomedical Corp
Robert Kelley Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 723,560 723,560 - - Stock Option (right to buy)
Talis Biomedical Corp
Robert Kelley Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 450,000 450,000 - - Stock Option (right to buy)
Talis Biomedical Corp
Robert Kelley Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2021 130,000 427,202 - - Stock Option (right to buy)
Coterra Energy
Robert Kelley Director Grant, award, or other acquisition of securities at price $ 16.83 per share. 15 Apr 2021 1,560 484,085 (0%) 0% 16.8 26,255 Common Stock
Coterra Energy
Robert Kelley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2021 12,380 482,525 (0%) 0% 0 Common Stock
Coterra Energy
Robert Kelley Director Gift of securities by or to the insider at price $ 0.00 per share. 15 Jan 2021 250,000 468,768 (0%) 0% 0 Common Stock
Coterra Energy
Robert Kelley Director Grant, award, or other acquisition of securities at price $ 19.07 per share. 15 Jan 2021 1,377 470,145 (0%) 0% 19.1 26,259 Common Stock
Coterra Energy
Robert Kelley Director Grant, award, or other acquisition of securities at price $ 19.47 per share. 15 Oct 2020 1,349 718,768 (0%) 0% 19.5 26,265 Common Stock
Coterra Energy
Robert Kelley Director Grant, award, or other acquisition of securities at price $ 17.85 per share. 15 Jul 2020 1,471 717,419 (0%) 0% 17.8 26,257 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades